RCT-evaluation of Retzius-sparing Robotic Prostatectomy
Not Applicable
- Conditions
- Urinary IncontinenceProstate Cancer
- Interventions
- Procedure: robotic Prostatectomy (RARP)
- Registration Number
- NCT03787823
- Lead Sponsor
- Heidelberg University
- Brief Summary
Prospective randomized blinded RCT comparing Transdouglas Prostatectomy to classical transperitoneal anterior radical prostatectomy
- Detailed Description
We will evaluate functional urinary and sexual recovery, oncologic outcomes and postoperative complications in patients over a follow up period of 12 months
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 186
Inclusion Criteria
- Indication for radical prostatectomy
- >18 years old
- Literate
- Preoperatively continent
- informed signed consent for study
Exclusion Criteria
- cT4-Cancer
- Withdrawl of consent to study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description anterior transperitoneal RARP robotic Prostatectomy (RARP) Arm A randomizes men with an indication for radical robotic Prostatectomy (RARP) to anterior transperitoneal RARP Retzius-sparing RARP robotic Prostatectomy (RARP) Arm B randomizes men with an indication for radical robotic Prostatectomy (RARP) to retzius-sparing transdouglas RARP
- Primary Outcome Measures
Name Time Method Urinary continence 1 Week after Prostatectomy Pad use
- Secondary Outcome Measures
Name Time Method postoperative PSA 12 months Resection margine pathology report, approximately 1 week postoperatively Urinary continence 3, 6 and 12 months after Prostatectomy Pad use
Postoperative complications First 12 months after Prostatectomy
Trial Locations
- Locations (1)
University of Heidelberg
🇩🇪Heidelberg, Germany